Mirae Asset Global ETFs Holdings
HRMY icon

Mirae Asset Global ETFs Holdings’s Harmony Biosciences HRMY Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$575K Buy
20,532
+258
+1% +$8.46K ﹤0.01% 1817
2025
Q4 		$759K Sell
20,274
-48
-0.2% -$1.58K ﹤0.01% 1674
2025
Q3 		$560K Sell
20,322
-3,649
-15% -$126K ﹤0.01% 1818
2025
Q2 		$757K Buy
23,971
+1,320
+6% +$42.5K ﹤0.01% 1586
2025
Q1 		$752K Buy
22,651
+984
+5% +$35.3K ﹤0.01% 1638
2024
Q4 		$746K Buy
21,667
+5,099
+31% +$175K ﹤0.01% 1707
2024
Q3 		$663K Buy
16,568
+298
+2% +$10.5K ﹤0.01% 1772
2024
Q2 		$491K Buy
+16,270
New +$489K ﹤0.01% 1838

Other funds holding HRMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's HRMY Position: Q1 2026 in Review

Mirae Asset Global ETFs Holdings increased its Harmony Biosciences (HRMY) stake by 1.3% in Q1 2026, buying an estimated $8.46K and bringing the position to 20,532 shares worth $575K. The position accounts for ﹤0.01% of the portfolio, ranked #1817.

Mirae Asset Global ETFs Holdings first reported a position in HRMY in Q2 2024 and has held it in 8 quarters since. The position peaked at $759K in Q4 2025. 309 funds tracked by Wall St. Rank hold HRMY as of Q1 2026.

  • Mirae Asset Global ETFs Holdings held 20,532 shares of Harmony Biosciences worth $575K as of Q1 2026.
  • Mirae Asset Global ETFs Holdings bought 258 Harmony Biosciences shares in Q1 2026, an estimated $8.46K.
  • Harmony Biosciences made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q1 2026, its #1817 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in Harmony Biosciences in Q2 2024 and has held it in 8 quarters since.
  • Mirae Asset Global ETFs Holdings's Harmony Biosciences position peaked at $759K in Q4 2025.
  • 309 funds tracked by Wall St. Rank held Harmony Biosciences as of Q1 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q1 2026, filed 15 May 2026.